Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
Amgen’s Acquisition of Horizon Therapeutics
Newbury Street Acquisition Corp.’s $1.85 Billion SPAC Transaction with Infinite Reality
Akerman represented Newbury Street Acquisition Corp. on the deal, while Fried Frank represented Infinite Reality. Newbury Street Acquisition Corporation, a special purpose acquisition company, announced a definitive...
Mirvac Limited’s Replacement of AMP Capital Investors Limited
Ashurst has advised Mirvac Limited on the deal. Mirvac Limited proposed the replacement of AMP Capital Investors Limited (AMPCI) as trustee of AMP Capital Wholesale Office...
Wesfarmers Limited’s A$770 Million Acquisition Of Australian Pharmaceutical Industries Limited
Ashurst has advised Australian Pharmaceutical Industries Limited on the deal. API, Wesfarmers and Wesfarmers Limited (Wesfarmers Parent) has entered into a Scheme Implementation Deed (SID), pursuant...
Woolworths Group Limited’s A$2 Billion Off-Market Share Buy-Back
Ashurst has advised Woolworths Group Limited on the matter. The current strength of the Woolworths Group balance sheet and the underlying strength of the business will...
Woolworths Group Limited’s A$12 Billion Demerger of Endeavour Group
Ashurst has advised Woolworths Group Limited on the proposed demerger of Endeavour Group, assisted by King & Wood Mallesons. The proposed demerger is the final step in...
Catalyze’s Acquisition of PermaCity
McDermott Will & Emery represented PermaCity in the transaction while Farella Braun + Martel advised Catalyze. Catalyze executed its acquisition of PermaCity, a solar developer and installer. Headquartered...